TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
TransMedics Group, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$71.60+0.82 (+1.16%)
Close on Oct 19, 2026
- Market cap
- $2.91B
- P/E (TTM)
- 18.6
- Dividend yield
- 0.00%
TransMedics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
| Measure | TransMedics | Industry median |
|---|---|---|
| Market Cap | $2.48B | $229.23M |
| Enterprise Value | $2.03B | $194.73M |
| PE Ratio | 18.60 | 33.41 |
| PS Ratio | 3.71 | 3.14 |
| PB Ratio | 4.79 | 3.19 |
| P/TBV Ratio | 4.90 | 4.69 |
| P/FCF Ratio | 31.41 | 27.25 |
| P/OCF Ratio | 17.01 | 22.23 |
Enterprise value
| Measure | TransMedics | Industry median |
|---|---|---|
| EV / Sales | 3.04 | 2.93 |
| EV / EBITDA | 17.20 | 19.97 |
| EV / EBIT | 24.88 | 25.47 |
| EV / FCF | 25.68 | 27.85 |
Income (trailing twelve months)
| Measure | TransMedics | Industry median |
|---|---|---|
| Revenue | $668.47M | $102.39M |
| Gross Profit | $392.35M | $60.36M |
| Operating Income | $81.61M | -$4.31M |
| Pretax Income | $72.55M | -$2.26M |
| Net Income | $151.70M | -$6.57M |
| EBITDA | $118.03M | -$1.98M |
| EPS (Diluted) | $3.85 | -$0.07 |
Margins
| Measure | TransMedics | Industry median |
|---|---|---|
| Gross Margin | 58.7% | 55.1% |
| Operating Margin | 12.2% | -6.04% |
| Pretax Margin | 10.9% | -4.11% |
| Profit Margin | 22.7% | -10.5% |
| EBITDA Margin | 17.7% | -2.67% |
| FCF Margin | 11.8% | -0.30% |
Returns
| Measure | TransMedics | Industry median |
|---|---|---|
| Return on Equity (ROE) | 36.3% | -19.2% |
| Return on Assets (ROA) | 12.9% | -13.3% |
| Return on Capital Employed (ROCE) | 5.97% | -9.07% |
Growth
| Measure | TransMedics | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 25.8% | 8.85% |
| Net Income Growth (YoY) | 111.7% | 10.6% |
| EPS Growth (YoY) | 99.5% | 10.6% |
| FCF Growth (YoY) | 355.5% | 10.6% |
| Revenue Growth (3Y CAGR) | 86.4% | 7.08% |
| Revenue Growth (5Y CAGR) | 88.2% | 11.8% |
Balance sheet
| Measure | TransMedics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $472.68M | $37.33M |
| Total Debt | $20.00M | $72.66M |
| Net Cash (Debt) | $452.68M | $3.92M |
| Net Cash Per Share | $13.05 | $0.28 |
| Equity (Book Value) | $518.05M | $57.36M |
| Book Value Per Share | $14.94 | $2.81 |
| Tangible Book Value | $506.50M | $10.71M |
| Working Capital | $552.84M | $54.64M |
Financial position
| Measure | TransMedics | Industry median |
|---|---|---|
| Current Ratio | 6.62 | 2.50 |
| Quick Ratio | 5.87 | 1.54 |
| Debt / Equity | 0.04 | 0.38 |
| Debt / EBITDA | 0.17 | 2.31 |
| Debt / FCF | 0.25 | 3.50 |
| Net Debt / EBITDA | -3.84 | 1.53 |
| Interest Coverage | 3.84 | -1.81 |
Cash flow (trailing twelve months)
| Measure | TransMedics | Industry median |
|---|---|---|
| Operating Cash Flow | $145.93M | -$653.46K |
| Capital Expenditures | -$66.89M | -$3.69M |
| Free Cash Flow | $79.04M | -$835.02K |
| FCF Per Share | $2.28 | -$0.02 |
Efficiency
| Measure | TransMedics | Industry median |
|---|---|---|
| Asset Turnover | 0.57 | 0.59 |
| Inventory Turnover | 5.94 | 2.21 |
| Revenue Per Employee | $744.40K | $322.75K |
| Profits Per Employee | $168.93K | -$52.11K |
| Employee Count | 898 | 197 |
Dividends and yields
| Measure | TransMedics | Industry median |
|---|---|---|
| Earnings Yield | 6.11% | -6.92% |
| FCF Yield | 3.18% | -0.62% |
| Dividend Yield | 0.00% | 0.81% |
| Shareholder Yield | 0.00% | 0.84% |
| Dividend Per Share | $0.00 | $0.72 |
| Years of Dividend Growth | 0 | 0 |
Shares
| Measure | TransMedics | Industry median |
|---|---|---|
| Shares Outstanding | 34,675,100 | 44,856,700 |
| Shares Change (YoY) | 4.77% | 3.35% |
| Shares Change (QoQ) | 0.24% | 0.27% |
| Float | 33,339,400 | 36,934,400 |
| Shares Held by Insiders | 3.85% | 10.6% |
| Shares Held by Institutions | 100.4% | 63.5% |
Taxes
| Measure | TransMedics | Industry median |
|---|---|---|
| Income Tax | -$79.15M | $1.52M |
| Effective Tax Rate | -109.1% | 18.6% |
Scores
| Measure | TransMedics | Industry median |
|---|---|---|
| Graham Number | $35.97 | $34.37 |
| Graham Upside | -49.8% | -58.3% |
| Altman Z-Score | 2.42 | 1.95 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -1.44 | -2.64 |
Calculated by StockData from TransMedics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.